Mednet Reports
PHYSICIAN PERSPECTIVE - Viewpoint based on the following article: J Allergy Clin Immunol 2010;125(3):600-8.
Current Control and Future Risk of Asthma Exacerbations: Maintenance and Reliever Strategies Revisited
May 2012
Guest Editor: Malcolm Sears, MB, ChB, FRACP, FRCPC, FAAAAI Professor of Medicine Division of Respirology St. Joseph’s HealthcareEndowed Chair in Respiratory Epidemiology McMaster UniversityHamilton, Ontario Introduction In...
RESSOURCE LINE
VACCINE
Spring 2012
NACI: New recommendations for the quadrivalent HPV vaccine for malesNational Advisory Committee on Immunization. Canada Communicable Disease Report January 2012;38:ACS-7. Recommendations for the use of the quadrivalent human papillomavirus...
MEDPOINT - 22nd European Congress on Clinical Microbiology and Infectious Diseases (ECCMID)
Primary Treatment of Invasive Aspergillosis in Hematology Patients
London, UK / March 31- April 3, 2012
London - The first randomized study of combination therapy in the treatment of invasive aspergillosis (IA) has provided new evidence-based guidance for hematological malignancy patients, including allograft hematopoietic stem cell...
PRIORITY PRESS - Annual Meeting of the Canadian Society of Nephrology
Thrombotic Microangiopathies: Focus on Atypical Hemolytic-uremic Syndrome
St. John’s, Newfoundland and Labrador / April 25-30, 2012
St. John’s - Thrombotic microangiopathies are microvascular occlusive disorders characterized by systemic aggregation of platelets, thrombocytopenia and mechanical injury to red blood cells. In the more common hemolytic uremic...
PHYSICIAN PERSPECTIVE - Viewpoint based on the following articles: Santolaya et al. Lancet 2012;379:617-24, Gossger et al. JAMA 2012;307(6):573-82.
Closing the Gap on N. meningitidis: Potential for Imminent Disease Control
April 2012
Guest Editor: Ronald Gold, MD, MPHFormer Head, Division of Infectious DiseaseThe Hospital for Sick ChildrenToronto, OntarioProfessor of Pediatrics (Retired) Faculty of Medicine, University of TorontoMedical AdvisorMeningitis Research...
PRIORITY PRESS - 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Real-world Clinical Experience Treating Gram-positive Infections
London, UK / March 31-April 3, 2012
London - Several new sets of data were presented at ECCMID that provided guidance on the efficacy of some of the most effective antibiotics for the treatment of serious Gram-positive infections. One of these was the ongoing European...
MEDICAL FRONTIERS - XVI International Symposium on Atherosclerosis
Cardiovascular Disease to Diabetes Prevention: The Potential of CETP Inhibition and Modulation
Sydney, Australia / March 25-29, 2012
Sydney - It is generally accepted that for every 0.1 mmol/L increase in HDL-C, there is an associated coronary artery disease risk reduction of ~10%. While raising HDL-C levels reduces the risk of atherosclerosis, a more specific focus on...
MEDI-NEWS - Based on Canada Communicable Disease Report (CCDR) January 2012;37:ACS-7.
NACI Update on Human Papillomavirus (HPV) Vaccines: New Focus on Male Vaccination
In 2006, the quadrivalent human papillomavirus vaccine (HPV) was authorized in Canada for use in females between the ages of 9 and 26 years for the prevention of infection caused by HPV types 6, 11, 16 and 18. These types lead to cervical...
MEDPOINT - The Canadian Society of Hospital Pharmacists Annual Professional Practice Conference
Update on Hyponatremia Management Strategies
Toronto, Ontario / February 4-8, 2012
Toronto - Hyponatremia is among the most common electrolyte disturbances encountered in hospitalized patients. Until recently, the heterogeneous treatment approaches have often been ineffective or potentially risky. There are many causes of...
MEDICAL FRONTIERS - Canadian Digestive Diseases Week
New Standard for Hepatitis C Treatment
Montréal, Quebec / February 24-27, 2012
Montréal - The burden of hepatitis C viral (HCV) disease is growing. At present, about 250,000 individuals in Canada are infected. An estimated 8000 to 10,000 new cases emerge each year, the majority of which are genotype 1. Many...
